Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) FCF Margin (2020 - 2025)

RxSight's FCF Margin history spans 6 years, with the latest figure at 6.91% for Q4 2025.

  • For Q4 2025, FCF Margin rose 1623.0% year-over-year to 6.91%; the TTM value through Dec 2025 reached 14.38%, up 162.0%, while the annual FY2025 figure was 14.38%, 162.0% up from the prior year.
  • FCF Margin reached 6.91% in Q4 2025 per RXST's latest filing, down from 5.83% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1.38% in Q3 2024 to a low of 308.55% in Q1 2021.
  • Average FCF Margin over 5 years is 87.85%, with a median of 42.79% recorded in 2023.
  • Peak YoY movement for FCF Margin: tumbled -21042bps in 2021, then surged 13684bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 124.9% in 2021, then rose by 20bps to 100.05% in 2022, then soared by 71bps to 29.29% in 2023, then increased by 21bps to 23.14% in 2024, then skyrocketed by 70bps to 6.91% in 2025.
  • Per Business Quant, the three most recent readings for RXST's FCF Margin are 6.91% (Q4 2025), 5.83% (Q3 2025), and 18.68% (Q2 2025).